The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary ProBioGen AG announce the agreement to produce over 40 million doses per…
ProBioGen AG today announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering
all aspects of cell line development, process development and GMP manufacturing at 1000 L bioreactor scale.
ProBioGen will now advance the…
The current pandemic has shown very clearly how important it is to translate medical research results into practice. Promoting this process of translation is the task of the Berlin Institute of Health (BIH), which was integrated into the Charité last…
What is the Speed Lecture Award?
Young scientists present in three minutes their new projects and ideas in life sciences and healthcare industries in front of the BIONNALE audience of more than 600 experts from academia, science and business.
Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite with a total area of around 270…
ProBioGen AG is delighted to announce the signing of a service agreement for Nobelpharma’s highly relevant vaccine project.
Earlier work confirmed already the versatility and benefit of ProBioGen’s vaccine development platform, consisting of the…
With beginning of 2021 Glycotope will offer its Contract Development Organization (CDO) and Clinical Lab services under the brand name FyoniBio®, the service branch of Glycotope.
With 20 years of history in biopharma development FyoniBio® is in a…
Epidemiologic investigation of peptide signatures, immunity, genetic predisposition, and alterations in SARS-CoV-2 (EPI-Dx)
Enhancement of Target Cell Killing for Innovative Therapies
Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on patients…
